Virtus ETF Advisers’s Endocyte, Inc. Common Stock ECYT Stock Holding History

Virtus ETF Advisers’s Portfolio ECYT Stock Details ECYT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q4	–	Sell	-31,923	Closed	-$567K	–	420
2018 Q3	$567K	Sell	31,923 -23,422	-42%	-$402K	0.06%	108
2018 Q2	$764K	Buy	+55,345	New	+$657K	0.68%	58

Other funds holding ECYT

OTC

Opera Trading Capital Paris, France $419M AUM 0.58% 1-Year Est. Return

Claro Advisors Boston, Massachusetts $953M AUM 24.79% 1-Year Est. Return

Virtus ETF Advisers's ECYT Position: Q4 2018 in Review

Virtus ETF Advisers sold out of Endocyte, Inc. Common Stock (ECYT) in Q4 2018, closing a stake of 31,923 shares — an estimated $567K sold.

Virtus ETF Advisers first reported a position in ECYT in Q2 2018 and held it in 2 quarters. The position peaked at $764K in Q2 2018. 2 funds tracked by Wall St. Rank hold ECYT as of Q4 2018.

Virtus ETF Advisers reported no remaining Endocyte, Inc. Common Stock position as of Q4 2018 after selling out during the quarter.
Virtus ETF Advisers sold 31,923 Endocyte, Inc. Common Stock shares in Q4 2018, an estimated $567K.
Virtus ETF Advisers first reported a position in Endocyte, Inc. Common Stock in Q2 2018 and held it in 2 quarters.
Virtus ETF Advisers's Endocyte, Inc. Common Stock position peaked at $764K in Q2 2018.
2 funds tracked by Wall St. Rank held Endocyte, Inc. Common Stock as of Q4 2018.

Based on Virtus ETF Advisers's 13F filing for Q4 2018, filed 5 Feb 2019.